These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22234817)

  • 1. Alveolar soft part sarcoma in childhood: is Sunitinib-Sutent® treatment an effective approach?
    Hilbert M; Mary P; Larroquet M; Serinet MO; Helfre S; Brisse H; Coulomb A; Orbach D
    Pediatr Blood Cancer; 2012 Mar; 58(3):475-6. PubMed ID: 22234817
    [No Abstract]   [Full Text] [Related]  

  • 2. Necrosis of a skin autograft after short-term treatment with sunitinib in a 14-year-old girl with metastatic alveolar soft part sarcoma of the thigh.
    Hanzer M; Nebl A; Spendel S; Pilhatsch A; Urban C; Benesch M
    Klin Padiatr; 2010 May; 222(3):184-6. PubMed ID: 20514624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of multidrug resistant advanced alveolar soft part sarcoma with sunitinib.
    Ghose A; Tariq Z; Veltri S
    Am J Ther; 2012 Jan; 19(1):e56-8. PubMed ID: 20634674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective analysis of 14 consecutive Chinese patients with unresectable or metastatic alveolar soft part sarcoma treated with sunitinib.
    Li T; Wang L; Wang H; Zhang S; Atikan Kawuli ; Zhang X; Luo Z; Wang C
    Invest New Drugs; 2016 Dec; 34(6):701-706. PubMed ID: 27604635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular-endothelial-growth-factor (VEGF) expression and possible response to angiogenesis inhibitor bevacizumab in metastatic alveolar soft part sarcoma.
    Azizi AA; Haberler C; Czech T; Gupper A; Prayer D; Breitschopf H; Acker T; Slavc I
    Lancet Oncol; 2006 Jun; 7(6):521-3. PubMed ID: 16750504
    [No Abstract]   [Full Text] [Related]  

  • 6. Durable clinical activity of single-agent bevacizumab in a nonagenarian patient with metastatic alveolar soft part sarcoma.
    Mir O; Boudou-Rouquette P; Larousserie F; Blanchet B; Babinet A; Anract P; Goldwasser F
    Anticancer Drugs; 2012 Aug; 23(7):745-8. PubMed ID: 22331039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to sunitinib malate in advanced alveolar soft part sarcoma.
    Stacchiotti S; Tamborini E; Marrari A; Brich S; Rota SA; Orsenigo M; Crippa F; Morosi C; Gronchi A; Pierotti MA; Casali PG; Pilotti S
    Clin Cancer Res; 2009 Feb; 15(3):1096-104. PubMed ID: 19188185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early clinical data with small-molecule vascular endothelial growth factor tyrosine kinase receptor inhibitors.
    Clin Lung Cancer; 2004 Sep; 6(2):74-6. PubMed ID: 15476593
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term results of therapy with sunitinib in metastatic alveolar soft part sarcoma.
    Jagodzińska-Mucha P; Świtaj T; Kozak K; Koseła-Paterczyk H; Klimczak A; Ługowska I; Rogala P; Wągrodzki M; Falkowski S; Rutkowski P
    Tumori; 2017 May; 103(3):231-235. PubMed ID: 28291905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term survival in a metastatic alveolar soft part sarcoma at the time of diagnosis: a case with 17 years of follow-up.
    Kos FT; Uncu D; Oksuzoglu B; Aksoy S; Ozdemir N; Odabas H; Isik M; Civelek B; Zengin N
    J BUON; 2011; 16(2):376-7. PubMed ID: 21766518
    [No Abstract]   [Full Text] [Related]  

  • 11. [Leg ulcerations and sunitinib].
    Guyot-Caquelin P; Granel-Brocard F; Cuny JF; Trechot P; Spaeth D; Marchal A; Barbaud A; Schmutz JL
    Ann Dermatol Venereol; 2010 Oct; 137(10):626-9. PubMed ID: 20932442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiangiogenic treatment as a pre-operative management of alveolar soft-part sarcoma.
    Conde N; Cruz O; Albert A; Mora J
    Pediatr Blood Cancer; 2011 Dec; 57(6):1071-3. PubMed ID: 21744483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacia's SU5416 not effective.
    Expert Rev Anticancer Ther; 2002 Feb; 2(1):5. PubMed ID: 12113066
    [No Abstract]   [Full Text] [Related]  

  • 14. Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect.
    Stacchiotti S; Negri T; Zaffaroni N; Palassini E; Morosi C; Brich S; Conca E; Bozzi F; Cassinelli G; Gronchi A; Casali PG; Pilotti S
    Ann Oncol; 2011 Jul; 22(7):1682-1690. PubMed ID: 21242589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical features and prognosis of alveolar soft part sarcoma].
    Xu LB; Yu SJ; Shao YF; Zhang HT; Zhao ZG
    Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):778-80. PubMed ID: 18396693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lingual alveolar soft part sarcoma in a child managed successfully with surgery and chemotherapy.
    Kumar M; Patne S; Vishwanath A; Hasan Z
    Indian J Cancer; 2010; 47(2):234-5. PubMed ID: 20448401
    [No Abstract]   [Full Text] [Related]  

  • 17. Stereotactic radiosurgery as a primary treatment for metastatic skull base alveolar soft part sarcoma: a case report.
    Shinya Y; Hasegawa H; Kawashima M; Shin M; Takahashi W; Kobayashi H; Saito N
    Acta Neurochir (Wien); 2021 Feb; 163(2):351-355. PubMed ID: 32686069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case records of the Massachusetts General Hospital. Case 17-2008. A 63-year-old man with metastatic renal-cell carcinoma.
    Michaelson MD; Iliopoulos O; McDermott DF; McGovern FJ; Harisinghani MG; Oliva E
    N Engl J Med; 2008 May; 358(22):2389-96. PubMed ID: 18509125
    [No Abstract]   [Full Text] [Related]  

  • 19. Metastatic alveolar soft part sarcoma presenting as a dural-based cerebral mass.
    Perry JR; Bilbao JM
    Neurosurgery; 1994 Jan; 34(1):168-70. PubMed ID: 8121554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic adamantinoma responds to treatment with receptor tyrosine kinase inhibitor.
    Dudek AZ; Murthaiah PK; Franklin M; Truskinovsky AM
    Acta Oncol; 2010; 49(1):101-4. PubMed ID: 19412810
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.